Latest Insulin Stories
DANBURY, Conn., Sept. 27, 2012 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) will present experimental data from its ultra-rapid-acting prandial insulin analog program at the 48th annual meeting of the European Association for the Study of Diabetes (EASD) being held October 1-5, 2012 in Berlin, Germany. Biodel Poster # 906 "Development of ultra-rapid-acting prandial insulin analogues requires chelation of zinc ions and charge masking to increase the rate of subcutaneous absorption,"...
MELBOURNE, Australia, Sept. 26, 2012 /PRNewswire/ -- CSL Limited has developed a new drug candidate that is able to prevent the development of type 2 diabetes and reverse its progression in animal models of the disease. The drug candidate blocks signalling by a protein known as Vascular Endothelial Growth Factor B (VEGF-B) and this prevents fat from accumulating in the "wrong" places, such as in muscles and in the heart. As a result, cells within these tissues are once again able to...
HORW, Switzerland, Sept. 26, 2012 /PRNewswire/ -- CeQur SA, a company focused on the development and commercialization of simple insulin delivery devices, announced the completion of a clinical study with the company's PaQ(® )Insulin Delivery Device. The study was designed to evaluate the ability of people with type 2 diabetes to use PaQ in replacing their multiple daily insulin injections required to control their blood sugar. Study endpoints included glycemic control, patient...
ALBANY, New York, September 26, 2012 /PRNewswire/ -- According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com) "Global Diabetes Devices Market and Diabetes Drugs Market - Industry Scenario, Trends, Analysis, Size, Share and Forecast, 2011 - 2018 [http://www.transparencymarketresearch.com/diabetes-devices-market.html ]," the global diabetes devices and drugs market was worth USD 50.8 billion in 2011 and is expected to...
According to a new study on adiponectin and raspberry ketone, obesity may be treated by regulating the levels of a key hormone in the body. (PRWEB) September 25, 2012 Researchers at the University of Alberta have reported that a specific type of gene therapy involving Adiponectin and Raspberry Ketone can actually help fight obesity. The study from The Journal of Nutrition & Diabetes concluded that adiponectin gene therapy ameliorates the metabolic abnormalities caused by feeding mice...
RIDGEFIELD, Conn. and INDIANAPOLIS, Sept. 24, 2012 /PRNewswire/ -- Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) will present data for three molecules, including two investigational compounds, from their Diabetes Alliance portfolio at the 48th European Association for the Study of Diabetes (EASD) Annual Meeting in Berlin, 1-5 October 2012. Now in its second year, the Boehringer Ingelheim and Lilly Diabetes Alliance continues its commitment to address patient needs...
Scientists have been trying to explain the causes of diabetes for many years. Researchers at the University of Copenhagen and Novo Nordisk A/S have now shown that the increased activity of one particular iron-transport protein destroys insulin-producing beta cells. In addition, the new research shows that mice without this iron transporter are protected against developing diabetes. These results have just been published in the prestigious journal Cell Metabolism. Almost 300,000 Danes have...
KNOXVILLE, Tenn., Sept. 20, 2012 /PRNewswire/ -- How would you like to experience the effects of running three miles or staving off Type 2 diabetes without making drastic changes in your lifestyle? With nutrition supplements developed by a UT professor, you can. (Photo: http://photos.prnewswire.com/prnh/20120920/CL78334 ) NuSirt Sciences Inc., founded by professor emeritus of nutrition Michael Zemel, has released a weight management product called NuShape, and a product for healthy...
HOLLYWOOD, Fla., Sept. 20, 2012 /PRNewswire-USNewswire/ -- The Diabetes Research Institute Foundation and Insulin Nation, the first all-digital, interactive diabetes publication, are partnering to bring news about research toward a cure to the millions now living with this disease. Beginning this month, Insulin Nation will include an ongoing feature titled "Cure Insight" that highlights the cure-focused research underway at the Diabetes Research Institute (DRI) at the University of...
ALBANY, New York, September 19, 2012 /PRNewswire/ -- According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com) "Insulin Market - Global and China Scenario, Trends, Industry Analysis, Size, Share and Forecast, 2011 - 2018 [http://www.transparencymarketresearch.com/insulin-market.html ]" the global insulin market was worth USD 12,476.3 million in 2011 and is expected to reach USD 32,346.7 million in 2018, growing at a...
Latest Insulin Reference Libraries
The pancreas is a digestive and an endocrine organ with both endocrine and exocrine functions. It is about six inches long located in the upper portion of the abdominal cavity. The head of the pancreas lies within the indentation of the duodenum and is connected to it by the pancreatic duct. The uncinate process extends from the head and the neck connects to the body of the pancreas, which lies directly behind the stomach. The tail of the pancreas extends to the left side of the body and is...
Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...
